Cite
MLA Citation
Heii Arai et al.. “P1–338: Safety, tolerability and immunogenicity of an immunotherapeutic vaccine (vanutide cridificar [ACC‐001]) and the QS‐21 adjuvant in Japanese individuals with mild‐to‐moderate Alzheimer's disease: A phase IIa, multicenter, randomized, adjuvant and placebo clinical trial.” Alzheimer's & dementia, vol. 9, n.d., p. P282. http://access.bl.uk/ark:/81055/vdc_100103412957.0x000022